NeuroSense Therapeutics News

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 12 16:33 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 5 09:33 ET

NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 4 16:37 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 28, 2023 09:00 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 16, 2023 16:01 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 23, 2023 16:06 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 1, 2023 08:50 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 14, 2023 16:30 ET

NeuroSense Therapeutics: FY2022 Annual Report

20-F | NeuroSense Therapeutics Ltd. (0001875091) (Filer)

Mar 22, 2023 09:21 ET

NeuroSense Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

Jan 19, 2023 16:31 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Aug 31, 2022 09:00 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

May 31, 2022 09:00 ET

NeuroSense Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 14, 2022 17:28 ET

NeuroSense Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 31, 2022 16:10 ET